Evidence map›Paper›PMID 28265898›Full record

ArticleNeuroscience bulletin2018

Spinal CCL2 Promotes Central Sensitization, Long-Term Potentiation, and Inflammatory Pain via CCR2: Further Insights into Molecular, Synaptic, and Cellular Mechanisms.

Rou-Gang Xie, Yong-Jing Gao, Chul-Kyu Park, Ning Lu, Ceng Luo, Wen-Ting Wang, Sheng-Xi Wu, Ru-Rong Ji

Abstract read
In one paragraph

Article in Neuroscience bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 81 citations in OpenAlex.

  1. Glial cells in neuropathic pain.Physiological reviews · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Sigma-1 receptor targeting inhibits connexin 43 based intercellular communication in chronic neuropathic pain.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Article
  14. Immune mediated support of metastasis: Implication for bone invasion.Cancer communications (London, England) · 2024
    Review
  15. Article
  16. Review
  17. Role of M1/M2 macrophages in pain modulation.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Rou-Gang XieDepartment of Neurobiology and Collaborative Innovation Center for Brain Science, The Fourth Military Medical University, Xi'an, 710032, China. rgxie@fmmu.edu.cn.
Yong-Jing GaoPain Research Laboratory, Institute of Nautical Medicine, Jiangsu Key laboratory of Neuroregeneration, Nantong University, Nantong, 226001, China.
Chul-Kyu ParkDepartment of Physiology, College of Medicine, Gachon University, Incheon, 21999, Republic of Korea.
Ning LuInstitutes of Brain Science and State Key Laboratory of Medical Neurobiology, Collaborative Innovation Center for Brain Science, Fudan University, Shanghai, 200032, China.
Ceng LuoDepartment of Neurobiology and Collaborative Innovation Center for Brain Science, The Fourth Military Medical University, Xi'an, 710032, China.
Wen-Ting WangDepartment of Neurobiology and Collaborative Innovation Center for Brain Science, The Fourth Military Medical University, Xi'an, 710032, China.
Sheng-Xi WuDepartment of Neurobiology and Collaborative Innovation Center for Brain Science, The Fourth Military Medical University, Xi'an, 710032, China.
Ru-Rong JiDepartment of Anesthesiology, Duke University Medical Center, Durham, NC, 27710, USA. ru-rong.ji@duke.edu.
Air Force Medical University · CNDuke Medical Center · USGachon University · KRNantong University · CNState Key Laboratory of Medical Neurobiology

Funding

Neuronal and glial interactions of neuropathic painR01DE017794 · NIDCR · DUKE UNIVERSITY · PI BUCHHEIT, THOMAS · 2006 to 2021
$6.6M
Hemichannels, Astrocytic Release, and Neuropathic PainR01DE022743 · NIDCR · DUKE UNIVERSITY · PI JI, RU-RONG, NEDERGAARD, MAIKEN · 2012 to 2016
$2.0M
Resolution pathway of painR01NS087988 · NINDS · DUKE UNIVERSITY · PI JI, RU-RONG · 2014 to 2018
$1.7M
NIDCR NIH HHS R01 DE017794NIDCR NIH HHS R01 DE022743NINDS NIH HHS R01 NS087988
6 · The paper itself

Abstract

Mounting evidence supports an important role of chemokines, produced by spinal cord astrocytes, in promoting central sensitization and chronic pain. In particular, CCL2 (C-C motif chemokine ligand 2) has been shown to enhance N-methyl-D-aspartate (NMDA)-induced currents in spinal outer lamina II (IIo) neurons. However, the exact molecular, synaptic, and cellular mechanisms by which CCL2 modulates central sensitization are still unclear. We found that spinal injection of the CCR2 antagonist RS504393 attenuated CCL2- and inflammation-induced hyperalgesia. Single-cell RT-PCR revealed CCR2 expression in excitatory vesicular glutamate transporter subtype 2-positive (VGLUT2

Indexed as

AnimalsBenzoxazinesChemokine CCL2Excitatory Amino Acid AgentsExcitatory Amino Acid AgonistsFemaleFreund's AdjuvantHyperalgesiaLong-Term PotentiationLuminescent ProteinsMaleMiceMice, Inbred C57BLMice, TransgenicMyelitisNeuronsBenzoxazinesCcl2 protein, mouseChemokine CCL2Excitatory Amino Acid AgentsExcitatory Amino Acid AgonistsFreund's AdjuvantLuminescent ProteinsRS 504393Slc17a6 protein, mouseSomatostatinSpiro CompoundsVesicular Glutamate Transport Protein 2Vesicular Inhibitory Amino Acid Transport ProteinsViaat protein, mouseC–C motif chemokine ligand 2 (CCL2)ChemokinesMonocyte chemoattractant protein 1 (MCP-1)Neuron–glial interaction

Identifiers

PMID28265898
PMCPMC5587365
OpenAlexW2593815272

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.